Volatility in Bio ETF Market and Regulatory Efforts to Overhaul Disclosure System
Volatility in Bio ETF Market and Regulatory Efforts to Overhaul Disclosure System
Financial authorities are moving to comprehensively reform the disclosure system for pharmaceutical and biotech companies. This initiative comes amid concerns that valuations based on technology transfer expectations are diverging significantly from actual cash flows, especially since many of the market cap leaders on Kosdaq are biotech firms. Enhanced transparency and improved trust are seen as necessary measures to stabilize the sector. Recently, volatility has increased in bio ETFs, with investors and asset managers placing greater emphasis on the liquidity and stability of underlying assets. In particular, the sharp one-month share price decline of Samchundang Pharm, a prominent biotech stock on Kosdaq, falling by 58.15%, has negatively impacted the performance of related bio ETFs. Asset managers are reducing or excluding the stock from ETF portfolios, citing suspected price manipulation and the requirement for additional clinical trials for generic drug registration as key drivers of the selloff. Samchundang Pharm has announced strong legal action in response to these allegations. While initiatives for regulatory reform and firm-level responses are being pursued to restore market confidence, continued monitoring of biotechnology stocks and ETF market volatility remains crucial.
Related News
뉴스핌10 hours ago
Focusing on 'Cash' Over 'Potential'…Bio Disclosure Overhaul and Valuation Restructuring Shake ETFsSeoul = NewsPim - Reporter Lee Nayoung reports that financial authorities have undertaken a comprehensive overhaul of the disclosure system for pharmaceutical and bio companies. This move comes as the discrepancy between valuations based on license-out (L/O) expectations and actual cash flow continues to widen, increasing the volatility of KOSDAQ bio stocks.
딜사이트21 hours ago
[ETF Matchup] Direct Hit to Returns from Samchundang Pharm's Plunge… Asset Managers Continuously Cut Losses - DealSiteSamchundang Shares Plunge to 480,000 KRW... High-Weight Inclusions in Mirae and KB Weekly Returns Down by 10%